EFNS Guidelines on Diagnosis and Treatment of Brain Metastases

brain metastases from lung cancer and in those of RPA class II, respectively [37 ,38] (class III evidence). When … tolerated for both initial therapy and secondary pro- … cell tumors and breast cancers, especially for chemo- …

More PDF Content

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force
Although many clini-shown a survival benefit for patients receiving thecians routinely place patients with brain metastases oncombined treatment (median survival 9-10 months vs. 52%) and a longer time of functional inde-Neurology (AAN) has reported on anticonvulsantpendence. Twelve studies,performance status, did not show any benefit with theeither randomized controlled trials or cohort studies,addition of surgery. The rapid dose fall-off of SRSacute venous thromboembolism (VTE) in cancer pa-minimizes the risk of damage to the surrounding nor-tients. The doseKPS 10Moribund; fatal processes progressing rapidlyKPS 0Deathdelivered is up to 60 Gy at 1 cm and the device is ex-planted after 3-6 days of treatment. Cairncross JG, Posner JB. Single dose radio-metastases using whole-body 18F-fluorodeoxyglucosesurgical treatment of recurrent previously irradiated pri-positron emission tomography. The Journal of the American Medical Associ-inoperable brain metastases of non-small cell lung cancer:ation 1998; 280: 1485-1489. De Angelis LM, Delattre JY, Posner JB. Final results of a phaseJournal of Radiation Oncology, Biology, Physics 1980; 6:II study of resection and gliasite brachytherapy for a1-9.

Download EFNS Guidelines on Diagnosis and Treatment of Brain Metastases pdf from www.efns.org, 8 pages, 109.44KB.